Sign In
|
|
Free Newsletters
Finance Resource Center
D&B Credit Reports
Businesses for Sale
What's Your Credit Emergency?
Thriving in Tough Times
Trade Magazines
Home
Topics
Bloggers
Franchises
Videos
Podcasts
Library
Ask the Experts
Shop Legal Forms
Find Vendors
Careers
|
Green Business
|
Starting a Business
|
Sales & Selling
|
Business Credit
|
Women in Business
|
Web Tools
|
Company Profiles
Careers
|
Green Business
|
Starting a Business
|
Sales & Selling
|
Business Credit
|
Women in Business
|
Web Tools
|
Company Profiles
Business Travel
|
Manufacturing
|
Retail
|
Sales
|
Starting a Business
|
Technology
|
> See All Topics
|
> See All Industries
Business Intelligence
|
Small Business Blog
|
Finance
|
Operations
|
Sales
|
Technology
|
> See All
AllBusiness AllStars
|
Franchise Directory
|
Buying a Franchise
|
Growing Your Franchise
|
Franchising Your Business
Human Resources
|
Franchises
|
Manufacturing
|
Marketing & Advertising
|
Sales
|
Technology
|
> See All
Finance
|
Green Business
|
Sales
|
Starting a Company
|
Technology
|
Women in Business
|
> See All
Professional Journals
|
Business Answers
|
Company Profiles
|
Glossary
Business Travel
|
Entrepreneurship
|
Finance
|
Franchising
|
Inventing
|
Sales
|
B2B Sales
Form Kits
|
Letter of Intent
|
Web Sites
|
Confidentiality
|
Employment
|
Consulting
|
Due Diligence
|
Demand Letters
|
Business Guides
> See All
Business Directory
|
Quote Center
|
Partner Resources
Enzyme Inhibitors
The best tips and advice from our vast library of articles, videos, and business tools
Browse Related Topics
Pharmaceutical Agents & Products
Pharmaceuticals & Biotechnology
Tools
Businesses for Sale
Business Cash Advance
Business Directory
Lead Lists
Free Magazines
Free Industry Resources
Newly Added Articles
Manager avoiding wild price swings
The business of flipping houses
Going green in the kitchen: Kitchens are the...
Finding love in China is good for business
Obama wins presidency; Democrats widen majority in...
PETER BILL ON PROPERTY
Deaths
Search Results
1-20
of 340 related articles
Best Of
Past 30 Days
This Year
Past 5 Years
All Dates
From Touted Vioxx Pain-Killer Drug To PD Rescue, Anti-COX-2 Blocker Salvages Dopamine Brain Neurons.
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research. "Ask your doctor if...
unaggregatedarticle
AVILA PRESENTS DATA ON ITS NOVEL, ORALLY-AVAILABLE PROTEASE INHIBITOR, AVL-181, DEMONSTRATING VIRAL CLEARANCE OFHEPATITIS C VIRUS IN PRE-CLINICAL MODELS.
Avila Therapeutics Inc (Avila) presented results of pre-clinical studies on its highly selective, small molecule Hepatitis C Virus...
unaggregatedarticle
Other News To Note.
o Ambrilia Biopharma Inc., of Montreal, presented preclinical dataon its series of HIV integrase inhibitors, showing their potential...
unaggregatedarticle
Vitae, GSK Enter Collaboration To Develop Renin Inhibitors.
West Coast Editor Talk about making the pulse race: Privately held Vitae Pharmaceuticals Inc., with its renin inhibitor...
unaggregatedarticle
Researchers from University of Texas, Health Science Center report details of new studies and findings in the area of chronic myeloid leukemia therapy.
Researchers detail in 'Class effects of tyrosine kinase inhibitorsin the treatment of chronic myeloid leukemia,' new data in...
unaggregatedarticle
Enanta In-Licenses Chiron's HCV Protease Inhibitor Group.
Staff Writer In the field of hepatitis C virus (HCV) protease inhibitors, Enanta Pharmaceuticals Inc. now has added...
unaggregatedarticle
Novartis Files For Approval Of Rasilez; Speedel Partner.
Washington Editor A drug developed in part by the Speedel Group, SPP100 (aliskiren),now is under FDA review after...
unaggregatedarticle
U.S. Patent Disclosures.
Advanced Tissue Sciences Inc., of La Jolla, Calif., was issued U.S. Patent No. 6,372,494 for the method of...
unaggregatedarticle
Concurrent Pharma Takes Over Allergan's Retinoids For Equity.
National Editor Acquiring the same development team that discovered the topical tazarotene known as Tazorac - though not...
unaggregatedarticle
NewCo News: Viamet Gets $4 Million Series A For Targeting Metalloenzymes.
Staff Writer Viamet Pharmaceuticals Inc. raised $4 million in a Series A financing to support its preclinical development...
unaggregatedarticle
Scientists at University of Texas target enzyme research.
"Molecules that block nitric oxide's (NO) biosynthesis are of significant interest. For example, nitric oxide synthase (NOS) inhibitorshave...
unaggregatedarticle
Isis Presents Interim ISIS 2503 Phase II Pancreatic Cancer Data.
Senior Staff Writer Isis Pharmaceuticals Inc. presented positive data from a planned interim analysis of a pancreatic cancer...
unaggregatedarticle
Pharmion, MethylGene Team For $100M Cancer Partnership.
Washington Editor In a new joint research venture worth up to $100 million, MethylGene Inc. and Pharmion are...
unaggregatedarticle
Astex, AstraZeneca Shape Potential $275M Agreement.
BioWorld International Correspondent LONDON - Astex Therapeutics Ltd. agreed to a deal with AstraZenecaplc for a range of...
unaggregatedarticle
Research reports on enzyme research from J.R. Simard and colleagues provide new insights.
According to recent research from Dortmund, Germany, "Kinase disregulation disrupts the intricate network of intracellular signaling pathways and...
unaggregatedarticle
NSAID's Under Cloud; New Targets For COX Research.
Science Editor As two retrospective analyses to be published in the Oct. 4, 2006,issue of the Journal of...
unaggregatedarticle
Athenagen Gains New AD Platform Via Zapaq Merger
Senior Staff Writer Adding a new Alzheimer's disease platform to its portfolio, Athenagen Inc. agreed to merge with...
unaggregatedarticle
Other News To Note.
o BioTime Inc., of Berkeley, Calif., reported the results of its studies in which rats survived the loss...
unaggregatedarticle
New Compounds, Mechanisms Could Harness MMP Inhibition.
Science Editor For the longest time, using matrix metalloproteinase inhibitors tocombat cancer has pretty much been one of...
unaggregatedarticle
Research on breast cancer therapy detailed by scientists at University of Bergen, Institute of Medicine
Data detailed in 'Nuclear receptor co-activators and HER-2/neu areupregulated in breast cancer patients during neo-adjuvant treatment with aromatase...
unaggregatedarticle
1-20
of 340 related articles
1
2
3
4
5
6
7
8
9
10
Next
Press Releases
NitroMed Special Meeting of Stockholders Further...
NitroMed Receives Revised Unsolicited Acquisition...
NitroMed Special Meeting of Stockholders Adjourned...
How to Turn Your Business Dream into a Successful Reality
Napa Valley business owners tell Sumer Morenz of D&B Digital TV how they turned passion into bottom-line success.
Franchise Finder
Find your perfect franchise
Choose your location and industry and we'll show you the most relevant franchises.
Industry:
All Industries
Automotive Franchises
Business-to-Business Franchises
Children's Franchises
General Service Franchises
Health and Wellness Franchises
Home Service Franchises
Personal Care Franchises
Personal Finance Franchises
Pet Franchises
Restaurant and Food Franchises
Retail Franchises
Travel and Leisure Franchises
Location:
All Locations
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Worldwide
Africa
Asia
Australia/New Zealand
Canada
Central America
Europe
Mexico
Middle East
South America
Premium Content
Inhibitors of cyclin-dependent kinases as...
Fermentation microbiology and biotechnology, 2d ed.
Advanced materials.(Highlights)